Re-establishing tolerance to DNA in humanized and murine models of SLE

Autoimmunity Reviews

Volumn 9, Issue 7, 2010, Pages 499-502

  Nikolova, Kalina ^a   Mihaylova, Nikolina ^a   Voynova, Elisaveta ^a   Kerekov, Nikola ^a   Gesheva, Vera ^a   Prechl, Jozsef ^b   Nikolova, Maria ^c   Tchorbanov, Andrey ^a  

^a INSTITUTE OF MICROBIOLOGY   (Bulgaria)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^c NATIONAL CENTER OF INFECTIOUS AND PARASITIC DISEASES   (Bulgaria)

Author keywords

Chimeric molecules; Inhibitory B cell receptors; SCID models of SLE

Indexed keywords

B LYMPHOCYTE RECEPTOR; FC RECEPTOR IIB; ANTINUCLEAR ANTIBODY; BISPECIFIC ANTIBODY; DNA;

B LYMPHOCYTE; CELL DIFFERENTIATION; GENE SILENCING; GLOMERULONEPHRITIS; HUMAN; IMMUNOREACTIVITY; LYMPHOCYTE DEPLETION; NEGATIVE FEEDBACK; NONHUMAN; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMA CELL; PROTEIN ENGINEERING; REVIEW; SIGNAL TRANSDUCTION; SPLEEN CELL; SYSTEMIC LUPUS ERYTHEMATOSUS; ANIMAL; BIOMIMETICS; DISEASE MODEL; FEEDBACK SYSTEM; GENETICS; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; IMMUNOTHERAPY; LUPUS ERYTHEMATOSUS, SYSTEMIC; MOUSE; TRENDS;

ANIMALS; ANTIBODIES, ANTINUCLEAR; ANTIBODIES, BISPECIFIC; B-LYMPHOCYTES; BIOMIMETICS; DISEASE MODELS, ANIMAL; DNA; FEEDBACK, PHYSIOLOGICAL; HUMANS; IMMUNE TOLERANCE; IMMUNOTHERAPY; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; PROTEIN ENGINEERING;

EID: 77951880152     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2010.02.009     Document Type: Review

References (30)

1. Shlomchik M.J., Madaio M.P., Ni D., Trounstein M., and Huszar D. The role of B cells in lpr/lpr-induced autoimmunity. J Exp Med 180 (1994) 1295-1306
2. Chan O.T., Hannum L.G., Haberman A.M., Madaio M.P., and Shlomchik M.J. A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus. J Exp Med 189 (1999) 1639-1648
3. Anolik J.H., Barnard J., Cappione A., Pugh-Bernard A.E., Felgar R.E., Looney R.J., et al. Rituximab improves peripheral B cell abnormalities in human systemic lupus erythematosus. Arthritis Rheum 50 (2004) 3580-3590
4. Anolik J.H., Barnard J., Owen T., Zheng B., Kemshetti S., Looney R.J., et al. Delayed memory B cell recovery in peripheral blood and lymphoid tissue in systemic lupus erythematosus after B cell depletion therapy. Arthritis Rheum 56 (2007) 3044-3056
5. Eisenberg R., and Looney R.J. The therapeutic potential of anti-CD20 "what do B-cells do?". Clin Immunol 117 (2005) 207-213
6. Looney R.J., Anolik J., and Sanz I. B lymphocytes in systemic lupus erythematosus: lessons from therapy targeting B cells. Lupus 13 (2004) 381-390
7. Dörner T., Kaufmann J., Wegener W., Teoh N., Goldenberg D., and Burmester G. Initial clinical trial of epratuzumab (humanized anti-CD22 antibody) for immunotherapy of systemic lupus erythematosus. Arthritis Res Ther R74 (2006)
8. Kalsi J.K., Martin A.C., Hirabayashi Y., et al. Functional and modelling studies of the binding of human monoclonal anti-DNA antibodies to DNA. Mol Immunol 33 (1996) 471-483
9. Hahn B.H. Antibodies to DNA. NEJM 19 (1998) 1359-1368
10. Chan O.T., Hannum L.G., Haberman A.M., Madaio M.P., and Shlomchik M.J. A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus. J Exp Med 189 (1999) 1639-1648
11. Shlomchik M.J., Craft J.E., and Mamula M.J. From T to B and back again: positive feedback in systemic autoimmune disease. Nat Rev Immunol 1 (2001) 147-153
12. Wang Y.H., and Diamond B. B cell receptor revision diminishes the autoreactive B cell response after antigen activation in mice. J Clin Invest 118 (2008) 2896-2907
13. Long E.O. Regulation of immune responses trough inhibitory receptors. Annu Rev Immunol 17 (1999) 875
14. Ravetch J.V., and Lanier L.L. Immune inhibitory receptors. Science 290 (2000) 84-89
15. Tarasenko T., Dean J.A., and Boland S. FcγRIIb as a modulator of autoimmune disease susceptibility. Autoimmunity 40 6 (2007) 409-417
16. Jozsi M., Prechl J., Bajtay Z., and Erdei A. Complement receptor type 1 (CD35) mediates inhibitory signals in human B lymphocytes. J Immunol 168 (2002) 2782-2788
17. Wagner C., Ochmann C., Schoels M., Giese T., Stegmaier S., Richter R., et al. The complement receptor 1, CR1 (CD35), mediates inhibitory signals in human T-lymphocytes. Mol Immunol 43 (2006) 643-651
18. Ahuja A., Shupe J., Dunn R., Kashgarian M., Kehry M., and Shlomchik M. Depletion of B cells in murine lupus: efficacy and resistance. J Immunol 179 (2007) 3351-3361
19. Lund F. Cytokine-producing B lymphocytes - key regulators of immunity. Curr Opin Immunol 20 (2008) 332-338
20. Bouaziz J.D., Yanada K., Venturi G.M., Wang Y., Tisch R., Poe J., et al. Therapeutic B cell depletion impairs adaptive and autoreactive CD4+ T cell activation in mice. PNAS 104 (2007) 20878-20883
21. Daëron M., and Lesourne R. Negative signaling in Fc receptor complexes. Adv Immunol 89 (2006) 39-86
22. Nimmerjahn F., and Ravetch J.V. Fcgamma receptors: old friends and new family members. Immunity 24 (2006) 19-28
23. Kaneko Y., Nimmerjahn F., Madaio M.P., and Ravetch J.V. Pathology and protection in nephrotoxic nephritis is determined by selective engagement of specific Fc receptors. J Exp Med 203 (2006) 789-797
24. Putterman C., Deocharan B., and Diamond B. Molecular analysis of the autoantibody response in peptide-induced autoimmunity. J Immunol 164 (2000) 2542-2549
25. Tchorbanov A., Voynova E., Mihaylova N., Todorov T., Nikolova M., Yomtova V., et al. Selective silencing of DNA-specific B lymphocytes delays lupus activity in MRL/lpr mice. Eur J Immunol 37 (2007) 3587-3596
26. Hoyer B.F., Moser K., Hauser A.E., Peddinghaus A., Voigt C., Eilat D., et al. Short-lived plasmablasts and long-lived plasma cells contribute to chronic humoral autoimmunity in NZB/W mice. J Exp Med 199 (2004) 1577-1584
27. Iking-Konert C., Stocks S., and Weinsberg F. First clinical trials of a new heteropolymer technology agent in normal healthy volunteers and patients with systemic lupus erythematosus: safety and proof of principle of the antigen-heteropolymer ETI-104. Ann Rheum Dis 63 (2004) 1104-1112
28. Voynova E., Tchorbanov A., Prechl J., Nikolova M., Baleva M., Erdei A., et al. An antibody-based construct carrying DNA-mimotope and targeting CR1(CD35) selectively suppresses human autoreactive B lymphocytes. Immunol Lett 116 (2008) 168-173
29. Sthoeger Z., Zinger H., Dekel B., Arditi F., Reisner Y., and Mozes E. Lupus manifestation in Severe Combined Immunodeficient (SCID) mice and in human/mouse radiation chimeras. J Clin Immunol 23 (2003) 91-99
30. Vladutiu A. The severe combined immunodeficient (SCID) mouse as a model for the study of autoimmune diseases. Clin Exp Immunol 93 (1993) 1-8